Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: A cohort study

BMJ Open

Volumn 2, Issue 2, 2012, Pages

  Pollock, Katrina M ^a   Tam, Herman ^a   Grass, Lisa ^a   Bowes, Sharleen ^a   Cooke, Graham S ^b   Pareek, Manish ^a   Montamat Sicotte, Damien ^a   Kapembwa, Moses ^c   Taylor, Graham P ^b   Lalvani, Ajit ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ALGORITHM; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HEALTH CARE PERSONNEL; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PROSPECTIVE STUDY; RESIDENTIAL AREA; SCREENING TEST; SMOKING; UNITED KINGDOM;

EID: 84860152220     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2011-000762     Document Type: Article

References (49)

1. HPA. Tuberculosis in the UK. Secondary Tuberculosis in the UK. 2011. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1317131791612
2. ECDC/WHO. Tuberculosis Surveillance in Europe Secondary Tuberculosis Surveillance in Europe. 2009. http://ecdc.europa.eu/en/publications/ Publications/1103-TB-SUR-2009.pdf
3. Akolo C, Adetifa I, Shepperd S, et al. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010; (1): CD000171.
4. Diedrich CR, Flynn JL. HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun 2011;79:1407-17.
5. Thwaites GE, Duc Bang N, Huy Dung N, et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with tuberculous meningitis. J Infect Dis 2005;192:2134-41. (Pubitemid 41779213)
6. Gonzalez OY, Adams G, Teeter LD, et al. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis 2003;7:1178-85. (Pubitemid 38004742)
7. Dye C, Williams BG. The population dynamics and control of tuberculosis. Science 2010;328:856-61.
8. Pooran A, Booth H, Miller RF, et al. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm Med 2010;10:7.
9. NICE. NICE Clinical Guideline 117. Tuberculosis. Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. 2011. http://www.nice.org.uk/nicemedia/live/13422/53642/53642.pdf
10. Bekker LG, Wood R. The changing natural history of tuberculosis and HIV coinfection in an urban area of hyperendemicity. Clin Infect Dis 2010;50(Suppl 3):S208-14.
11. WHO. TB/HIV Facts Secondary TB/HIV Facts. 2011. http://www.who.int/tb/ challenges/hiv/factsheet-hivtb-2011.pdf
12. Sonnenberg P, Glynn JR, Fielding K, et al. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis 2005;191:150-8. (Pubitemid 40096371)
13. Williams BG, Dye C. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science 2003;301:1535-7. (Pubitemid 37128545)
14. Sonnenberg P, Murray J, Glynn JR, et al. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001;358:1687-93. (Pubitemid 33124328)
15. Cobelens FG, Egwaga SM, van Ginkel T, et al. Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values. Clin Infect Dis 2006;43:634-9. (Pubitemid 44267127)
16. Diel R, Goletti D, Ferrara G, et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011;37:88-99.
17. Samandari T, Agizew TB, Nyirenda S, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebocontrolled trial. Lancet 2011;377:1588-98.
18. Pozniak AL, Coyne KM, Miller RF, et al. British HIV Association guidelines for the treatment of TB/HIV coinfection 2011. HIV Med 2011;12:517-24.
19. Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002;16:2285-93. (Pubitemid 35449014)
20. Mutsvangwa J, Millington KA, Chaka K, et al. Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden. Thorax 2010;65:315-20.
21. Dodd PJ, Millington KA, Ghani AC, et al. Interpreting tuberculin skin tests in a population with a high prevalence of HIV, tuberculosis, and nonspecific tuberculin sensitivity. Am J Epidemiol 2010;171:1037-45.
22. Millet JP, Orcau A, de Olalla PG, et al. Tuberculosis recurrence and its associated risk factors among successfully treated patients. J Epidemiol Community Health 2009;63:799-804.
23. Koppaka VR, Harvey E, Mertz B, et al. Risk factors associated with tuberculin skin test positivity among university students and the use of such factors in the development of a targeted screening program. Clin Infect Dis 2003;36:599-607. (Pubitemid 36259565)
24. Brock I, Ruhwald M, Lundgren B, et al. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 2006;7:56.
25. Jones S, de Gijsel D, Wallach FR, et al. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis 2007;11:1190-5. (Pubitemid 350146299)
26. Jee SH, Golub JE, Jo J, et al. Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 2009;170:1478-85.
27. Leung CC, Yew WW, Chan CK, et al. Smoking and tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2003;7:980-6. (Pubitemid 37237062)
28. Leung CC, Li T, Lam TH, et al. Smoking and tuberculosis among the elderly in Hong Kong. Am J Respir Crit Care Med 2004;170:1027-33. (Pubitemid 39425701)
29. Altet-Gomez MN, Alcaide J, Godoy P, et al. Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13, 038 cases. Int J Tuberc Lung Dis 2005;9:430-6. (Pubitemid 40524035)
30. Ktsanes VK, Williams WL, Boudreaux VV. The cumulative risk of tuberculin skin test conversion for five years of hospital employment. Am J Public Health 1986;76:65-7. (Pubitemid 16177554)
31. Baussano I, Bugiani M, Carosso A, et al. Risk of tuberculin conversion among healthcare workers and the adoption of preventive measures. Occup Environ Med 2007;64:161-6. (Pubitemid 46579824)
32. Baussano I, Nunn P, Williams B, et al. Tuberculosis among health care workers. Emerg Infect Dis 2011;17:488-94.
33. Grimes CZ, Hwang LY, Williams ML, et al. Tuberculosis infection in drug users: interferon-gamma release assay performance. Int J Tuberc Lung Dis 2007;11:1183-9. (Pubitemid 350146298)
34. O'Grady J, Hoelscher M, Atun R, et al. Tuberculosis in prisons in sub-Saharan Africadthe need for improved health services, surveillance and control. Tuberculosis (Edinb) 2011;91:173-8.
35. Baussano I, Williams BG, Nunn P, et al. Tuberculosis incidence in prisons: a systematic review. PLoS Med 2010;7:e1000381.
36. Dosanjh DP, Hinks TS, Innes JA, et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med 2008;148:325-36. (Pubitemid 351665463)
37. Pareek M, Watson JP, Ormerod LP, et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis 2011;11:435-44.
38. HPA. Diagnosed HIV-Infected Individuals Seen for Care. Survey of Prevalent HIV Infections Diagnosed (SOPHID). Black-African and Black-Caribbean Data Tables. 2011. http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/1221482345789
39. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50. (Pubitemid 19070537)
40. Aichelburg MC, Rieger A, Breitenecker F, et al. Detection and prediction of active tuberculosis disease by a whole-blood interferongamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009;48:954-62.
41. Latorre I, Martinez-Lacasa X, Font R, et al. IFN-gamma response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection. BMC Infect Dis 2010;10:348.
42. Stephan C, Wolf T, Goetsch U, et al. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 2008;22:2471-9.
43. Grant AD, Bansi L, Ainsworth J, et al. Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention? AIDS 2009;23:2507-15.
44. Karam F, Mbow F, Fletcher H, et al. Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS One 2008;3:e1441.
45. Liebeschuetz S, Bamber S, Ewer K, et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004;364:2196-203. (Pubitemid 40018449)
46. Mandalakas AM, Hesseling AC, Chegou NN, et al. High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 2008;12:417-23. (Pubitemid 351507255)
47. Cattamanchi A, Smith R, Steingart KR, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 2011;56:230-8.
48. Leidl L, Mayanja-Kizza H, Sotgiu G, et al. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J 2010;35:619-26.
49. Clark SA, Martin SL, Pozniak A, et al. Tuberculosis antigenspecific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol 2007;150:238-44. (Pubitemid 47609557)